Results 181 to 190 of about 36,503 (286)

Vonoprazan or Proton Pump Inhibitor for Gastric Endoscopic Submucosal Dissection in Patients Taking Antithrombotic Agents

Journal of Gastroenterology and Hepatology, Volume 40, Issue 8, Page 1890-1898, August 2025.
ABSTRACT Background and Aim Delayed bleeding is a major concern after gastric endoscopic submucosal dissection (ESD), especially in patients taking antithrombotic agents. The aim of this study was to evaluate the superiority of vonoprazan (VPZ) over proton pump inhibitor (PPI) in preventing delayed bleeding after gastric ESD in patients taking ...
Hiroyuki Shibata, Toshihisa Fujiyoshi, Noboru Kawata, Tomohiko Obayashi, Masaya Esaki, Masakazu Kikuchi, Naohiro Yoshida, Tsuguo Kamioka, Yoji Sasaki, Makoto Kobayashi, Muneyori Okita, Shigeyuki Matsui, Kazuhiro Furukawa, Masanao Nakamura, Naomi Kakushima, Mitsuhiro Fujishiro, Hiroki Kawashima   +16 more
wiley   +1 more source

Amitriptyline or Not, That Is the Question: Pharmacogenetic Testing of CYP2D6 and CYP2C19 Identifies Patients with Low or High Risk for Side Effects in Amitriptyline Therapy [PDF]

, 2005
Werner Steimer, Konstanze Zöpf, Silvia von Amelunxen, Herbert Pfeiffer, Julia Bachofer, Johannes Popp, Barbara Meßner, Werner Kissling, Stefan Leucht   +8 more
openalex   +1 more source

Synthesis and Biological Evaluation of Bicyclic Pyrazolines with Promising Antimicrobial Activities

ChemMedChem, Volume 20, Issue 14, July 18, 2025.
Continuous flow technology is exploited for the generation of bicyclic pyrazolines via photo‐click reactions. These heterocyclic species contain a valuable 3D scaffold along with a polar succinimide moiety. Subsequent antimicrobial testing reveals that halogenated moieties such as chlorine atoms and trifluoromethoxy groups enhance the potency of these ...
Debora Caviglia, Anna Maria Schito, Susanna Penco, Chiara Brullo, Marcus Baumann   +4 more
wiley   +1 more source

Effects of different PPIs, genetic difference in CYP2C19 status and antibiotic susceptibility patterns on the cure rate of H. pylori infection by one-week triple therapy: Results of a radomized trial in Japan

, 2001
Hideaki Kawabata, Takanobu Hayakumo, Masatugu Nakajima, Masahiro Tada, Shigeto Mizuno, Kunihilfo Kimoto, Masao Kobayashi, Yasuki Habu, Keisuke Kiyota, Hideto Inokuchi, Keiichi Kawai   +10 more
openalex   +1 more source

Effect of CYP2C19 polymorphism on rabeprazole induced nocturnal acid breakthrough

, 2001
Soo‐Heon Park, Jong‐Won Kim, Soo‐Youn Lee, Myung‐Gyu Choi, Jae Kwang Kim, Kyu Yong Choi, In Sik Chung, Hee Sik Sun, Doo Ho Park   +8 more
openalex   +1 more source

Different effects of fluvoxamine on rabeprazole pharmacokinetics in relation to CYP2C19 genotype status [PDF]

, 2005
Tsukasa Uno, Mikiko Shimizu, Norio Yasui‐Furukori, Kazunobu Sugawara, Tomonori Tateishi   +4 more
openalex   +1 more source

Major Allele Frequencies in <i>CYP2C9</i> and <i>CYP2C19</i> in Asian and European Populations: A Case Study to Disaggregate Data Among Large Racial Categories. [PDF]

J Pers Med
Nieh HV, Roman YM.
europepmc   +1 more source

Pharmacodynamic effects and kinetic disposition of rabeprazole in relation to CYP2C19 genotype in healthy Chinese subjects1 [PDF]

, 2005
Yongmei Hu, Jianming Xu, Mei Qiao, Xin-hua Xu, Shuyun Xu   +4 more
openalex   +1 more source

Pharmacogenetic Implications for Antidepressant Therapy in Major Depression: A Systematic Review Covering 2019-2024. [PDF]

J Clin Med
Fornaguera A, Miarons M.
europepmc   +1 more source

The prevalence of CYP2C19 genotypes in a population of healthy Dutch volunteers and apparent gender differences in phenotypes

, 2002
Wim J. Tamminga, Johan Wemer, B. Oosterhuis, Dick de Zeeuw, Lou F. M. H. de Leij, J. H. G. Jonkman   +5 more
openalex   +2 more sources